GlassScriptPhysician profile
Frank Oliver
NPI 1477113934
$1,355.98
in general payments reported to CMS, 2019-2025
19 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.00 · 2021: $36.75 · 2022: $51.24 · 2023: $201 · 2024: $818 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.10 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $266.20 | 2021-2024 | |
| Lilly USA, LLC | $190.95 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $189.08 | 2024-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $142.45 | 2023-2025 | |
| Glaxosmithkline, LLC. | $105.76 | 2023-2025 | Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $90.08 | 2023-2024 | Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $86.60 | 2023-2024 | |
| Amgen INC. | $58.01 | 2021-2025 | Evenity, Prolia |
| Amneal Pharmaceuticals LLC | $33.15 | 2023-2024 | Unithroid |
| Exact Sciences Corporation | $31.67 | 2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $25.84 | 2024 | Veozah |
| Beta Bionics, INC. | $23.18 | 2024 | Ilet Bionic Pancreas |
| Merck Sharp & Dohme LLC | $18.48 | 2024 | Capvaxive, Gardasil, Gardasil 9 |
| Boston Scientific Corporation | $16.70 | 2024 | Watchman Access System |
| Ibsa Pharma INC. | $16.53 | 2023 | Tirosint, Licart |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $16.52 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Paratek Pharmaceuticals, INC. | $16.05 | 2024 | Nuzyra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.48 | 2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.